Court Report - July 1, 2012

[author: Sherri Oslick]

Gavel About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases.

Cumberland Pharmaceuticals Inc. v. Sagent Agila LLC et al.
1:12-cv-00825; filed June 26, 2012 in the District Court of Delaware

• Plaintiff:  Cumberland Pharmaceuticals Inc.
• Defendants:  Sagent Agila LLC; Sagent Pharmaceuticals Inc.

Infringement of U.S. Patent No. 8,148,356 ("Acetylcysteine Composition and Uses Therefor," issued April 3, 2012) following a Paragraph IV certification as part of Sagent's filing of an ANDA to manufacture a generic version of Cumberland's Acetadote® (N-acetylcysteine  injection, used to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen).  View the complaint here.


Galderma Laboratories, L.P. et al. v. Actavis Mid Atlantic LLC
3:12-cv-02038; filed June 26, 2012 in the Northern District of Texas

• Plaintiffs:  Galderma Laboratories, L.P.; Galderma S.A.; Galderma Research & Development, S.N.C.
• Defendant:  Actavis Mid Atlantic LLC

Infringement of U.S. Patent Nos. 7,820,186 ("Gel Composition for Once-Daily Treatment of Common Acne Comprising a Combination of Benzoyl Peroxide and Adapalene and/or Adapalene Salt," issued October 26, 2010), 7,964,202 ("Method for Treatment of Common Acne," issued June 21, 2011), 8,071,644 ("Combinations of Adapalene and Benzoyl Peroxide for Treating Acne Lesions," issued December 6, 2011), 8,080,537 (same title, issued December 26, 2011), 8,105,618 ("Dermatological/Cosmetic Gels Comprising At Least One Retinoid and/or Retinoid Salt and Benzoyl Peroxide," issued January 31, 2012), and 8,129,362 ("Combination/Association of Adapalene and Benzoyl Peroxide for Treating Acne Lesions," issued March 6, 2012) following a Paragraph IV certification as part of Actavis' filing of an ANDA to manufacture a generic version of Galderma's Epiduo® Gel (adapalene and benzoyl peroxide, used to treat acne vulgaris).  View the complaint here.


Pfizer, Inc. et al. v. Mylan Pharmaceuticals Inc. et al.
1:12-cv-00106; filed June 26, 2012 in the Northern District of West Virginia

• Plaintiffs:  Pfizer, Inc.; Wyeth LLC; Wyeth Pharmaceuticals, Inc.; PF Prism C.V.
• Defendants:  Mylan Pharmaceuticals Inc.; Mylan Inc.

Pfizer Inc et al. v. Anchen Pharmaceuticals Inc et al.
2:12-cv-05535; filed June 25, 2012 in the Central District of California

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc; PF Prims C.V.
• Defendants:  Anchen Pharmaceuticals Inc.; Anchen Inc.

Pfizer Inc. et al. v. Watson Laboratories, Inc. Florida et al.
0:12-cv-61268; filed June 25, 2012 in the Southern District of Florida

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Watson Laboratories, Inc. Florida; Andrx Corp.; Watson Laboratories, Inc.; Watson Pharma, Inc.; Watson Pharmaceuticals, Inc.

Pfizer Inc. et al. v. Sandoz Inc.
3:12-cv-03880; filed June 25, 2012 in the District Court of New Jersey

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Sandoz Inc.

Pfizer Inc. et al. v. Zydus Pharmaceuticals (USA), Inc. et al.
3:12-cv-03893; filed June 25, 2012 in the District Court of New Jersey

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Zydus Pharmaceuticals (USA), Inc.; Cadila Healthcare Ltd.

Pfizer Inc. et al. v. Anchen Pharmaceuticals Inc. et al.
1:12-cv-00808; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Anchen Pharmaceuticals Inc.; Anchen Inc.

Pfizer Inc. et al. v. Roxane Laboratories Inc. et al.
1:12-cv-00813; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Roxane Laboratories Inc.; Boehringer Ingelheim Roxane Inc.

Pfizer Inc. et al. v. Apotex Inc. et al.
1:12-cv-00809; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Apotex Inc.; Apotex Corp.

Pfizer Inc. et al. v. Sandoz Inc.
1:12-cv-00814; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendant:  Sandoz Inc.

Pfizer Inc. et al. v. Breckenridge Pharmaceutical Inc. et al.
1:12-cv-00810; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Breckenridge Pharmaceutical Inc.; Alembic Pharmaceuticals Ltd.; Alembic Ltd.

Pfizer Inc. et al. v. Teva Pharmaceuticals USA Inc. et al.
1:12-cv-00815; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd.

Pfizer Inc. et al. v. Lupin Ltd. et al.
1:12-cv-00811; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Lupin Ltd. ; Lupin Pharmaceuticals Inc.

Pfizer Inc. et al. v. Watson Laboratories Inc. Florida et al.
1:12-cv-00816; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Watson Laboratories Inc. Florida; Andrx Corp.; Watson Laboratories Inc.; Watson Pharma Inc.; Watson Pharmaceuticals Inc.

Pfizer Inc. et al. v. Mylan Pharmaceuticals Inc. et al.
1:12-cv-00812; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Mylan Pharmaceuticals Inc.; Mylan Inc.

Pfizer Inc. et al. v. Wockhardt Ltd. et al.
1:12-cv-00817; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Wockhardt Ltd.; Wockhardt USA LLC

Pfizer Inc. et al. v. Zydus Pharmaceuticals USA Inc. et al.
1:12-cv-00818; filed June 22, 2012 in the District Court of Delaware

• Plaintiffs:  Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
• Defendants:  Zydus Pharmaceuticals USA Inc.; Cadila Healthcare Ltd.

The complaints in these cases are substantially identical.  Infringement of U.S. Patent No. 6,673,838 ("Succinate Salt of O-Desmethyl-Venlafaxine," issued January 6, 2004) following a Paragraph IV certification as part of defendants' filing of an ANDA to manufacture a generic version of Pfizer's Pristiq® (desvenlafaxine, used to treat depression).  View the Delaware Anchen complaint here.

 

Published In: Civil Procedure Updates, Intellectual Property Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDonnell Boehnen Hulbert & Berghoff LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »